Relationship between various clinical outcome assessments in patients with blepharospasm. - Wikidata - wikimedia - TriplyDB

Relationship between various clinical outcome assessments in patients with blepharospasm.

Relationship between various clinical outcome assessments in patients with blepharospasm.

http://www.wikidata.org/entity/Q43976256

about

Upper facial chorea in Huntington disease Development and validation of a clinical guideline for diagnosing blepharospasm.Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm.Pre-operative evaluations for DBS in dystonia.Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data.Dystonia rating scales: critique and recommendations The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm.Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins In vivo confocal microscopy of meibomian glands in primary blepharospasm: A prospective case-control study in a Chinese population.Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial.Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm Designing clinical trials for dystonia.Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm.Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy.Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders Blepharospasm in children and adolescents.Blepharospasm 40 years later.Changes in corneal aesthesiometry and the sub-basal nerve plexus in benign essential blepharospasm.Pallidal stimulation for medically intractable blepharospasm.The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm.Photophobia in primary headaches, in essential blepharospasm and in major depression.Early use of Xeomin neurotoxin for local anti-spasticity therapy for pes equines after acquired brain injury (ABI).Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation.Altered functional connectivity in blepharospasm/orofacial dystonia.Isolated focal dystonia phenotypes are associated with distinct patterns of altered microstructure Evaluation of Scheimpflug imaging parameters in blepharospasm and normal eyes

P2860

Q27321026-8CA90194-CAC4-47D4-B6D0-1F65BA77AC65 Q30544592-764E8969-4BEE-426C-A5A5-4490CB8ECA3A Q33935194-7D987E11-34DF-42F7-B4BB-C4AAFA590257 Q33938316-42A3F5E2-FA4D-4CEB-BAA5-ABE1433A93CC Q34037621-C4FED387-7E00-4041-9044-5A9552E4F824 Q34393230-CC86C89B-5D09-4E44-A094-C720456E5351 Q34647152-F76200E0-9657-4C2E-9A05-1284CC84A4CD Q35050218-A3DB3AFC-AEBD-4682-82EA-E84A4482C498 Q35681898-379B730A-CF2D-482D-B821-8A4EC2BEDA48 Q36046940-CEFB0ACB-AF93-4607-9A5E-370111C5B48B Q36667983-BF40015C-B7D1-49CF-95CC-CFAF25DD5CB1 Q37115101-6DEAD360-1843-4612-A120-BE33AC0EE12C Q37506514-8E358940-3AD1-4A91-8A30-A3E0E795AB79 Q37827385-E142445F-6DE0-43D0-BDBC-CCA3291DC7CA Q38320289-F7CBF093-07B8-4E04-BC87-F1FCBE287444 Q38432422-22389A0F-C3AC-41CB-8E37-E98893D39556 Q38618608-C5EBBBF0-3596-403D-AB41-778D40491D65 Q39130169-C11FCCD3-43B9-4A86-84DE-7B9221CBE28F Q42476048-DB02F566-EB54-4287-846A-ACC7E094F008 Q47446448-2C4AB7D0-F8CC-4D45-BCFA-519DAB031D77 Q47769889-36A9DF9D-F9DA-4C05-B6AE-08C348E494AF Q48042923-3F472AE3-7ED1-456C-87F5-37A43219CFE0 Q48870387-B89DB3AF-9A19-4E31-9776-6752510D8AB0 Q50017647-10228A93-8533-41BB-9B93-447635C0E9D9 Q54977584-E7CF757E-1E73-4126-A27D-E8CC4B24493D Q57040383-AFC61F52-BDE9-4A7C-B7CB-3AA2A5CD1867 Q58763167-8B9E9600-84DA-42C8-9445-8B1307944676

P2860

Relationship between various clinical outcome assessments in patients with blepharospasm.

http://www.wikidata.org/entity/Q43976256

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Relationship between various clinical outcome assessments in patients with blepharospasm.

@en

Relationship between various clinical outcome assessments in patients with blepharospasm.

@nl

type

label

Relationship between various clinical outcome assessments in patients with blepharospasm.

@en

Relationship between various clinical outcome assessments in patients with blepharospasm.

@nl

prefLabel

Relationship between various clinical outcome assessments in patients with blepharospasm.

@en

Relationship between various clinical outcome assessments in patients with blepharospasm.

@nl

P1433

Q43976256-6D2C2BF0-CD3F-494C-BBB7-429B8098DB0F

P1476

Q43976256-F50EFF44-AF65-4C36-AD9F-82BE4BBC46DF

P2093

Q43976256-13AD2A1E-DD72-4B71-8E48-D9FBD4F69CF4

Q43976256-9190E4E8-5893-40EA-A7C7-70066419E29A

Q43976256-9F549205-F474-4BBA-8C96-AE61571C7E9A

Q43976256-B9E041B1-ED01-43C0-9BE9-4163800123BF

P2860

Q43976256-0F02A1BE-28AE-41D6-B8F4-B3C5C6F0B73D

Q43976256-111659EE-900A-425B-AF78-08C591ECE355

Q43976256-13E6241A-FF2F-499C-ADF6-C3C3D8C1569F

Q43976256-14241D56-8383-4674-92F1-519C52556BBA

Q43976256-4D3E1603-DD5E-4F79-AA51-C9DE343FBF2E

Q43976256-514CE6F0-EC0C-4849-BDB5-FC32B97A7826

Q43976256-57B463A7-788F-4C9F-97A4-8ECF6D298E6B

Q43976256-626796F3-20AC-45C1-99ED-CD3E3AE15D07

Q43976256-9A63C44A-FB5D-4F8E-8642-111DCE1129A3

Q43976256-A6A22B22-DE2F-4344-A1D2-37AA6B446685

P304

Q43976256-5769E757-1316-421B-AC65-9FD652E9686C

P31

Q43976256-AC99E01C-FE6B-4D4F-8C7A-6C14D0FF2554

P356

Q43976256-E1917786-8D44-42C5-A20F-0E4094DC1D58

P407

Q43976256-A5F519ED-48BE-4028-90CC-21ADFDE63221

P433

Q43976256-D3F01B2C-2E0D-4FB8-9F3E-FD008FCA295E

P478

Q43976256-D4186D61-D9A3-4FB9-93BC-BD7CE08C1F9E

P50

Q43976256-B8009C1B-A3DC-4B19-89D1-336A3B018515

P577

Q43976256-32474F72-3BD8-41C1-92BC-B4E773F052FE

P698

Q43976256-6949349F-A196-44C1-B27B-92F37A482B54

P356

P1433

Movement Disorders

P1476

Relationship between various clinical outcome assessments in patients with blepharospasm.

@en

P2093

Christopher Kenney

http://www.w3.org/2001/XMLSchema#string

George Comes

http://www.w3.org/2001/XMLSchema#string

Roman Goertelmeyer

http://www.w3.org/2001/XMLSchema#string

Susanne Grafe

http://www.w3.org/2001/XMLSchema#string

P2860

Blepharospasm: a review of 264 patients.

Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients.

Health-related quality of life in neurology.

Epidemiology of focal and generalized dystonia in Rochester, Minnesota.

Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia

Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument.

Evidence-based review of patient-reported outcomes with botulinum toxin type A.

A family study on primary blepharospasm.

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Management of spasticity associated pain with botulinum toxin A.

P304

407-413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.22368

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Joseph Jankovic

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19053054

http://www.w3.org/2001/XMLSchema#string